| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |